In triple-negative breast cancer cells, EGFR signaling regulates IGF2BP3 transcription since the IGF2BP3 promoter activity decreased after MEK1/2 signaling inhibition downstream of EGFR (Samanta et al., 2012). This evidence concerns the gene EGFR and triple-negative breast carcinoma.